
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has announced a strategic partnership with Inofab Health. Together, ERT and Inofab will continue to develop patient-friendly solutions enabling at-home, patient-administered testing of the lung, supporting patient comfort and safety while keeping respiratory trials on track.
For more information, click






